Moreover, despite a lack of understanding about the prognostic role of TLR8 in PAAD, activation of TLR8 signaling has been widely believed to inhibit regulatory T cells (Tregs) function and enhance antitumor immunity35–37. The gene discussed is TLR8; the disease is pancreatic adenocarcinoma.